Table 2. Univariate associations between predictors and oncologic outcomes following radical cystectomy.
Recurrence-free survival |
Cancer-specific survival |
Overall survival |
||||
---|---|---|---|---|---|---|
Parameter | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value |
Haemoglobin, per 1 g/dl | 0.90 (0.86–0.94) | <0.001 | 0.87 (0.82–0.91) | <0.001 | 0.84 (0.82–0.87) | <0.001 |
Neutrophil–lymphocyte ratio, per 1-log unita | 1.49 (1.22–1.81) | <0.001 | 1.58 (1.32–1.90) | <0.001 | 1.74 (1.43–2.11) | <0.001 |
Lymphocyte–monocyte ratio, per 1-log unita | 0.66 (0.55–0.79) | <0.001 | 0.69 (0.53–0.91) | 0.009 | 0.70 (0.55–0.88) | 0.002 |
Platelet–lymphocyte ratio, per 100 units | 1.22 (1.08–1.38) | 0.002 | 1.21 (1.05–1.41) | 0.01 | 1.16 (1.02–1.33) | 0.03 |
Abbreviations: CI=confidence interval; HR=hazard ratio.
Log-transformed.